Home » Topics » Conferences

Conferences
RSS

Potential antipsychotics under development at Taisho/Nihon Nohyaku

Sep. 16, 1997

More on SE-205, a new MMP/TNF inhibitor from DuPont Merck

Sep. 16, 1997

NCI evaluates stability of SarCNU

Sep. 16, 1997

New compounds for influenza targeting cap-dependent endonuclease

Sep. 16, 1997

Merck Frosst reports further data on COX-2 inhibitor L-768277

Sep. 16, 1997

Potent and selective COX-2 inhibitors synthesized at Boehringer Ingelheim

Sep. 16, 1997

Glaxo Wellcome develops new influenza sialidase inhibitors

Sep. 16, 1997

Mitsubishi describes synthesis and activity of MKC-242

Sep. 15, 1997

Novel neuroprotective agent developed at Takeda

Sep. 15, 1997

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.